(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
@ $40.16
Išleistas: 14 vas. 2024 @ 18:36
Grąža: 11.29%
Ankstesnis signalas: vas. 13 - 16:30
Ankstesnis signalas:
Grąža: -0.88 %
Live Chart Being Loaded With Signals
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide...
Stats | |
---|---|
Šios dienos apimtis | 76 473.00 |
Vidutinė apimtis | 109 138 |
Rinkos kapitalizacija | 893.13M |
EPS | $0 ( 2024-04-03 ) |
Kita pelno data | ( $0.180 ) 2024-07-04 |
Last Dividend | $0.0600 ( 2023-10-27 ) |
Next Dividend | $0 ( N/A ) |
P/E | 85.94 |
ATR14 | $0.0400 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-01 | Woltosz Walter S | Sell | 19 410 | Common Stock |
2024-04-01 | Woltosz Walter S | Sell | 590 | Common Stock |
2024-03-28 | Szot Daniel | Buy | 30 000 | Stock Options (Right to Buy) |
2024-03-01 | Woltosz Walter S | Sell | 17 600 | Common Stock |
2024-03-01 | Woltosz Walter S | Sell | 2 400 | Common Stock |
INSIDER POWER |
---|
-41.29 |
Last 97 transactions |
Buy: 243 785 | Sell: 655 613 |
Tūris Koreliacija
Simulations Plus Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
EMBCV | 0.822 |
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Simulations Plus Inc Koreliacija - Valiuta/Žaliavos
Simulations Plus Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $59.58M |
Bruto pelnas: | $47.95M (80.48 %) |
EPS: | $0.500 |
FY | 2023 |
Pajamos: | $59.58M |
Bruto pelnas: | $47.95M (80.48 %) |
EPS: | $0.500 |
FY | 2022 |
Pajamos: | $53.91M |
Bruto pelnas: | $43.08M (79.92 %) |
EPS: | $0.620 |
FY | 2021 |
Pajamos: | $46.47M |
Bruto pelnas: | $35.87M (77.19 %) |
EPS: | $0.490 |
Financial Reports:
No articles found.
Simulations Plus Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0600 (N/A) |
$0.0600 (N/A) |
$0.0600 (N/A) |
$0.0600 (N/A) |
$0.0600 (N/A) |
$0.0600 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0500 | 2012-02-16 |
Last Dividend | $0.0600 | 2023-10-27 |
Next Dividend | $0 | N/A |
Payout Date | 2023-11-06 | |
Next Payout Date | N/A | |
# dividends | 48 | -- |
Total Paid Out | $2.69 | -- |
Avg. Dividend % Per Year | 0.37% | -- |
Score | 4.4 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.47 | |
Div. Directional Score | 7.58 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.340 | 11.30% |
2013 | $0.100 | 2.29% |
2014 | $0.200 | 3.92% |
2015 | $0.200 | 2.95% |
2016 | $0.200 | 2.07% |
2017 | $0.210 | 2.33% |
2018 | $0.240 | 1.53% |
2019 | $0.240 | 1.21% |
2020 | $0.240 | 0.84% |
2021 | $0.240 | 0.32% |
2022 | $0.240 | 0.48% |
2023 | $0.240 | 0.65% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.163 | 1.500 | 6.75 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0542 | 1.200 | 8.19 | 9.83 | [0 - 0.3] |
returnOnEquityTTM | 0.0611 | 1.500 | -0.433 | -0.649 | [0.1 - 1] |
payoutRatioTTM | 0.455 | -1.000 | 5.45 | -5.45 | [0 - 1] |
currentRatioTTM | 8.81 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 8.55 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.55 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.00532 | -1.500 | 9.91 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 6.31 | 1.000 | 8.77 | 8.77 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.880 | 2.00 | 9.71 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.639 | 2.00 | 9.68 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.00583 | -1.500 | 9.98 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.751 | 1.000 | 0.810 | 0.810 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.171 | 1.000 | 8.57 | 8.57 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 17.03 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.333 | 0.800 | -1.111 | -0.889 | [0.5 - 2] |
Total Score | 11.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 84.89 | 1.000 | 1.526 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0611 | 2.50 | -0.278 | -0.649 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.639 | 2.00 | 9.79 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.537 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.880 | 2.00 | 9.71 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.455 | 1.500 | 5.45 | -5.45 | [0 - 1] |
pegRatioTTM | -4.39 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.272 | 1.000 | 5.70 | 0 | [0.1 - 0.5] |
Total Score | 3.47 |
Simulations Plus Inc
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.